High Dose Nimodipine Treatment Adjunct - 1

High Dose Nimodipine Pharmacotherapy Adjunct

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00000332

Enrollment

Registered

1999-09-21

Start date

1998-05-31

Completion date

2000-04-30

Last updated

2017-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-Related Disorders

Brief summary

The purpose of this study is to determine if nimodipine is more effective than placebo in reducing stimulated craving for cocaine in cocaine dependent individuals denied access to cocaine in inpatient unit.

Interventions

DRUGNimodipine

Study design

Primary purpose

TREATMENT

Eligibility

Sex/Gender

ALL

Age

22 Years to 45 Years

Healthy volunteers

Inclusion criteria

Please contact site for information.

Design outcomes

Primary

Measure	Time frame
Stimulated and non-stimulated craving	—
Stimulated and non-stimulated withdrawal	—
Anxiety, depression	—
Heart rate	—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026